Ardent Health (ARDT) Q4 2025 earnings summary

Executive summary

• Achieved record-high full-year 2025 revenue of $6.32 billion (6% growth) and adjusted EBITDA of $545 million (9.3% growth), with margin expansion of 20 basis points to 8.6%.

• Fourth quarter 2025 revenue was $1.61 billion, nearly flat year-over-year, and adjusted EBITDA was $134 million, down 26.6% due to prior year state payment program benefits.

• Operating cash flow increased 49% to $471 million in 2025, with cash and equivalents rising to $710 million at year-end.

• IMPACT program initiatives delivered significant cost savings, especially in salaries, wages, and benefits, and are expected to provide $55 million in savings in 2026.

• Technology and AI deployment, including virtual care and AI Scribe, are enhancing efficiency, care quality, and revenue capture.

Financial highlights

• Full-year 2025 revenue: $6.32 billion (6% YoY growth); Q4 revenue: $1.61 billion (flat YoY).

• Adjusted EBITDA: $545 million for 2025 (9.3% YoY growth); Q4 adjusted EBITDA: $134 million (-26.6% YoY).

• Operating cash flow for 2025: $471 million (+49% YoY); free cash flow (net of NCI distributions): $170 million.

• Margins expanded to 8.6% (adjusted EBITDA) and 12.7% (pre-NCI adjusted EBITDAR).

• Lease-adjusted net leverage improved to 2.5x at year-end 2025; cash increased by $150 million to $710 million.

Outlook and guidance

• 2026 revenue guidance: $6.4–$6.7 billion; adjusted EBITDA: $485–$535 million; net income: $129–$183 million.

• Adjusted admissions growth expected at 1.5–2.5% for 2026.

• Capital expenditures projected at $225–$265 million for 2026.

• Guidance reflects headwinds from professional fee pressures, payor denials, and expiration of enhanced Exchange subsidies, offset by IMPACT program savings.

• Expect return to adjusted EBITDA growth in 2027 as headwinds are lapped and IMPACT savings build.